{"name":"ENA Respiratory Pty Ltd","slug":"ena-respiratory-pty-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"INNA-051","genericName":"INNA-051","slug":"inna-051","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"INNA-051","genericName":"INNA-051","slug":"inna-051","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNVXpCV25oMmg5aTBBVVZ2cGd1OG9aLUR0aTJJQ2ZHeXQ2TWdHU0gweVlLZ2dXbmVhLXlCaG55X1d2M18yT1J2bk5QbEtXY0JoYWZtbmVrWV96MHVBcW4yOWNaMDhVbWtDTGh1Vkc1UG05em1PaGhVYVRpcFZmbUhCaXBYVU5NcGNXbGljY29fSVUwTzhabmUzSDg3OXk1RS1zc0drUFBPSXJ5WFVyVmZ4RXRVSG92Tk11cFJoVG5sdmFxZTNJdk4wNmQ1VTBGSnNUZ09fbXN4NGpRZEgxYUJzZURPclZ3WnFjNlhaclEwWXBCSGZqdC1QMzNaMXU?oc=5","date":"2026-04-07","type":"trial","source":"Barchart.com","summary":"Influenza Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com","headline":"Influenza Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Develop Drugs for Market Entry | Delve","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-01","type":"trial","source":"simplywall.st","summary":"How Investors May Respond To AptarGroup (ATR) Powering ENA’s Phase II Intranasal Antiviral Study - simplywall.st","headline":"How Investors May Respond To AptarGroup (ATR) Powering ENA’s Phase II Intranasal Antiviral Study","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-22","type":"trial","source":"simplywall.st","summary":"AptarGroup’s Nasal Devices Gain Ground In Respiratory Trials And Leadership Shift - simplywall.st","headline":"AptarGroup’s Nasal Devices Gain Ground In Respiratory Trials And Leadership Shift","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AJBVV95cUxNZERaX3diS2NGdVNUSjZ6eFdvWUxrV1RRZGpmSW5mVnJxcHFSemIxTEVwN2toc2JlaVJHbWxJT19fY281bWRfc2cxcmRheHNrT1lxTzY2RXZGbFBRendIcWRjZl9DMGprcTgtdEhfeUw4eVdWQ3RGdmRHUkREUnROUVZqZ1NWQndWdmxtWFpfOFNLRmdQWW14aUl0eTMzamNncmRZcE0wWVJMWkFCUWpOcDYwMTNMRXV3TUVxVl9MZWhyQVNBWmtRamhGTHpzLVA1ZUlDVFhNSl9fR1Q2WWJaN2dmOHRHNHY2aUhOdUF5S1JKai1fNDZWMndJZmVHYW5zN3doZDcxYy1qeFgwR2lvZWVHS3NxeHdIdGtsQ29Nc084ZHBWazBxczdzZ1c4cml1ZFdKZlh2T0I2UUdEVE9vTE52ZWdPYnlBZVVicU5YU2NLT1FNMkVDVg?oc=5","date":"2026-01-29","type":"pipeline","source":"GlobeNewswire","summary":"ENA Respiratory Announces Dosing of First Participants in - GlobeNewswire","headline":"ENA Respiratory Announces Dosing of First Participants in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNaF91SXBZblhJU0x6bC1NejFtZW1RVnlmQ0xHNzVWamh3Q19vcVh0QWFHRmQ5OGxfdGtwR29aMXdFcmdJOXZWdkRaYTY3X1lyclhoM3hYbGNreVFDU1dkVXBHWC0wcnFyUTFmWGdLX2RKaXVNYkc2RUNMNGJfVDZubk5mR0MwZzFjUzdScjVodk53VmFLSlFoSGlhZzE1ck1rTmww?oc=5","date":"2025-10-23","type":"trial","source":"BioWorld News","summary":"Ena Respiratory raises AU$34M series B to fund phase II trial - BioWorld News","headline":"Ena Respiratory raises AU$34M series B to fund phase II trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxPcUtZM01oS29GYzkzbnJtOE1UTWNnTHJpbDlaTFlRcmtlS0d5ZGdUQmpWb245dGlUT0I0M1lLVGdWN3RrdGtzZ1M5dm9nVlBnenNkWG9lOXZEOW1uNVFzMElkYlZ3TGhNWDBYZUlxcFlYVHhNZnhxRHBmeEVXR2NsX3BQTUxucEVlZFZ1Rll1bXVjblFvd2FDMkxkck1KU1pEeHdJOGhMX0xqZkgtUzBnbGpIbEVKVDQ4dUVsNXZDZUxQMVlHa2VJcll1LXZOeGxTQ0pPclU1RjVralpYaks2NThycG9XS3NzVnA3NUZyYU5vLTFVM2NHV1dhWUs2WGRhVnpDdllpdlpFVTkyVktpbUFOTk52djNVR3llOGstUXdLc2pITlhibWlRRFk2WVpXSTYzSmlvSUdZSHVFUHRJeXh1a2xwY2VraW5rOTFiV0xtdVBi?oc=5","date":"2025-10-22","type":"trial","source":"GlobeNewswire","summary":"ENA Respiratory Attracts US$22.4m (AU$34m) to Fund Phase II - GlobeNewswire","headline":"ENA Respiratory Attracts US$22.4m (AU$34m) to Fund Phase II","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPdmVtWXVSTS1zR3BtVTJ4SVRwZlp1SUlKWHV6emJRUWtfa0IyWEtsS0lCS25VMUFMck9JMUNldXhqYjBwaE5KOWh3SEpMZHE3LWZiVlVaVWpZSEZjWHd1ajlnc1Y0eUMwTjV2YTA2Z3R4RGt0dGZYVnl1Ylp5YWJVeV9JOTB2ZWdnZjhPM1U3T09hQ1FGMFl1aUdFZmgzUDJoMng0a1FWWjRFSEFIckZIQWhTNVRvRWk3V09kdG10WnBKYm1LR1hCbTJoR2Z2eE5NMG1TLU9tZWpZWlBWXzZrZVo4ckwzS3g5MVow?oc=5","date":"2024-07-04","type":"trial","source":"PR Newswire","summary":"BK Virus Infection Market to Witness Surge in Growth During the Study Period (2020-2034) | DelveInsight - PR Newswire","headline":"BK Virus Infection Market to Witness Surge in Growth During the Study Period (2020-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPLXBxQS1LcGd5Q0U5aGgtUW9XaF81UUc3RVZzNnVOZnNrX21Gei1JRjBDbGhqT2FYcDNDcDRRc1lsNlgweFdvOUxoMG9CZkNnXzlsRC1WNTZYNzNzUWlnZXNDNmhfTEhjdVVCenU1aXd0bzJ1a0xRTE44S01wRDZxTndsc24zWk1aQ3htdXpLWklYdkkyUkRZTVdnQjVzazRQYkQtb1FjY0tnWll1cFl0Q2g1QW1kRFMtalhDLVEzNA?oc=5","date":"2023-09-12","type":"pipeline","source":"forbes.com.au","summary":"It beat the Covid virus, so why did this Aussie startup get $12m from the US military to start over? - forbes.com.au","headline":"It beat the Covid virus, so why did this Aussie startup get $12m from the US military to start over?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNYWdnSUNLaW1YQXd1WmNkSmRHa2h0NVBDVExwMTBXSlVRYUlJNlpDS0dOcmd6RXJRZ3lud1ZYYjdyMlQ0Mno5bF9tR2hBMUJrTDV1ME1RdndkcmxOb3Z3bUEyd3hyQ2JzT1VfODZsUVdFV3lleHM1cEtoZVl4RVhaLUphQTRFVWF1S0tFVllQUG1tNFJKNEk0S1AybnNFUll5Y2FiRzNyLVNId1lINVF1RXRRaWhkWjFhdUh6UHBlZFA4NXBGNXJyOTd6TE1NS3Q2S2VTeVNRdG5wRFIw?oc=5","date":"2022-09-02","type":"trial","source":"The University of Melbourne","summary":"Trial funded for nasal spray aimed at preventing respiratory infections in older people - The University of Melbourne","headline":"Trial funded for nasal spray aimed at preventing respiratory infections in older people","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQbnFfbDU2Vlc0ZW9BcnItOVEta2p2eVBmM3FaaFFERG5CS0tRd2JBd2ZtWXNOd0lXMEZYNG55LS1SaF82T3ltWDFnV2JVQmQzODJjT0RHSGdDOS1LcGJzemZzV2I2cjI1NnVEV0FFSFBKQXhVT05xZlhQQmxWMGNzTjYyOUtnUHczRGdCaTlCQjdjZ3FpbTZyaXZDdktWeWVKc09feVNtbVc5bEVGS09PR29ZSk52Z0t3UkhvbHFDZ2UtWHh3YklxYk45RUo3c1UtOUVZX0FILVozU1MzZTFfREZaYmo1dw?oc=5","date":"2022-08-31","type":"pipeline","source":"PR Newswire","summary":"Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight - PR Newswire","headline":"Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}